论文部分内容阅读
Bronchitol(吸入性甘露醇)日前获得欧洲销售许可,用于治疗≥18岁患者的囊性纤维病(cystic fibrosis,CF)。本品将率先在德国和英国上市,这些地区不需要药物划价和赔偿许可。Bronchitol是一种含有甘露醇干粉剂、采用手握式吸入器给药的专利制剂。它可润肺,帮助修复正常的肺脏
Bronchitol® (Inhaled Mannitol) has recently obtained a European sales license for the treatment of cystic fibrosis (CF) in patients ≥18 years of age. This product will be the first to be listed in Germany and the United Kingdom, these areas do not need drug pricing and compensation permits. Bronchitol is a patented formulation that contains a dry powder inhaler for mannitol administration. It helps the lungs and helps to repair the normal lungs